CD1a - Mouse monoclonal [CD1a007] to CD1a; CD1a antigen; T-cell surface antigen T6_Leu-6; hTa1 thymocyte antigen Monoclonal
- Known as:
- CD1a - Mouse mab [CD1a007] CD1a; CD1a antigenic; T-cellular surface antigenic T6_Leu-6; hTa1 thymocyte antigenic Monoclonal
- Catalog number:
- 20-272-192069
- Product Quantity:
- 0.5 ml
- Category:
- -
- Supplier:
- GenWay
- Gene target:
- CD1a - Mouse monoclonal [CD1a007] CD1a; antigen; T-cell surface antigen T6_Leu-6; hTa1 thymocyte Monoclonal
Related genes to: CD1a - Mouse monoclonal [CD1a007] to CD1a; CD1a antigen; T-cell surface antigen T6_Leu-6; hTa1 thymocyte antigen Monoclonal
- Gene:
- CD1A NIH gene
- Name:
- CD1a molecule
- Previous symbol:
- CD1
- Synonyms:
- -
- Chromosome:
- 1q23.1
- Locus Type:
- gene with protein product
- Date approved:
- 1988-05-11
- Date modifiied:
- 2017-07-07
Related products to: CD1a - Mouse monoclonal [CD1a007] to CD1a; CD1a antigen; T-cell surface antigen T6_Leu-6; hTa1 thymocyte antigen Monoclonal
Related articles to: CD1a - Mouse monoclonal [CD1a007] to CD1a; CD1a antigen; T-cell surface antigen T6_Leu-6; hTa1 thymocyte antigen Monoclonal
- NSG (NOD/Scid IL2Rγ) mice reconstituted with PBMCs donated by patients with ulcerative colitis or Crohn's disease highly reflect the respective pathological phenotype. To determine whether these findings could be applicable to atopic dermatitis (AD) and psoriasis vulgaris (PV), PBMCs isolated from patients with AD and PV were first subjected to immunological profiling. Subsequently, NSG mice were reconstituted with these PBMCs. Hierarchical clustering and network analysis revealed a distinct profile of patients with AD and PV with activated CD4+ T cells (CD69, CD25) occupying a central position in the AD network and CD4+ CD134+ cells acting as the main hub in the PV network. After dermal application of DMSO, both NSG mice reconstituted with PBMCs from donors with AD (ie, NSG-AD mice) and NSG mice reconstituted with PBMCs from donors with PV (ie, NSG-PV mice) exhibited increased clinical, skin, and histological scores. Immunohistochemical analysis, frequencies of splenic human leukocytes, and cytokine expression levels indicated that CD4+ CD69+ cells, M1 and TSLP receptor-expressing monocytes, switched B cells, and monocyte chemoattractant protein 3 were the driving factors of inflammation in NSG-AD mice. In contrast, inflammation in NSG-PV mice was characterized by an increase in fibroblasts in the epidermis, frequencies of CD1a-expressing monocytes, and IL-17 levels. Therefore, the pathological phenotypes of NSG-AD mice and NSG-PV mice differ and partially reflect the respective human diseases. - Source: PubMed
Publication date: 2024/02/03
Schindler MariettaSchuster-Winkelmann PaulaWeß VeronikaCzell SophiaRueff FranziskaWollenberg AndreasSiebeck MatthiasGropp Roswitha - Langerhans cell histiocytosis (LCH) is a rare disorder affecting usually children and rarely adults. The most common site affected is bone. The involvement of the thyroid gland in LCH is extremely rare and it is usually observed in an adult as a multisystemic disease. Adult males presented with anterior neck swelling, and fine needle aspiration cytology (FNAC) diagnosed it as suspicious for malignancy. On frozen sectioning, differential diagnosis was given as non-Hodgkin lymphoma and poorly differentiated malignancy. On immunohistochemistry (IHC), tumor cells were positive for CD1a and S100p. Thus, the final diagnosis offered was LCH-thyroid. The pathogenesis is unclear and believed to be related to immune dysfunction, cytokine mediators, viral infection, smoking, and genetic factors. Due to its rarity, thyroid LCH is often misinterpreted as other common disorders of the thyroid and results in delayed diagnosis. This case highlights the importance of histomorphology and the use of ancillary techniques such as IHC to arrive at a diagnosis in time and hence the treatment. - Source: PubMed
Publication date: 2024/05/10
Patel DharaDoshi PreetiKesarkhane MilindMani Narayan S - Histiocytic and dendritic cell neoplasms comprise diverse tumors originating from the mononuclear phagocytic system, which includes monocytes, macrophages, and dendritic cells. The 5th edition of the World Health Organization (WHO) classification updating the categorization of these tumors, reflecting a deeper understanding of their pathogenesis.In this updated classification system, tumors are categorized as Langerhans cell and other dendritic cell neoplasms, histiocyte/macrophage neoplasms, and plasmacytoid dendritic cell neoplasms. Follicular dendritic cell neoplasms are classified as mesenchymal dendritic cell neoplasms within the stroma-derived neoplasms of lymphoid tissues.Each subtype of histiocytic and dendritic cell neoplasms exhibits distinct morphological characteristics. They also show a characteristic immunophenotypic profile marked by various markers such as CD1a, CD207/langerin, S100, CD68, CD163, CD4, CD123, CD21, CD23, CD35, and ALK, and hematolymphoid markers such as CD45 and CD43. In situ hybridization for EBV-encoded small RNA (EBER) identifies a particular subtype. Immunoprofiling plays a critical role in determining the cell of origin and identifying the specific subtype of tumors. There are frequent genomic alterations in these neoplasms, especially in the mitogen-activated protein kinase pathway, including BRAF (notably BRAF V600E), MAP2K1, KRAS, and NRAS mutations, and ALK gene translocation.This review aims to offer a comprehensive and updated overview of histiocytic and dendritic cell neoplasms, focusing on their ontogeny, morphological aspects, immunophenotypic profiles, and molecular genetics. This comprehensive approach is essential for accurately differentiating and classifying neoplasms according to the updated WHO classification. - Source: PubMed
Publication date: 2024/05/07
Yoon Sun Och - A xanthoma is a rare bone condition consisting of a predominant collection of lipid-rich, foamy histiocytes. The central xanthoma of the jaws is a unique benign tumor. - Source: PubMed
Publication date: 2024/05/07
Georgiev AGenova SUchikov PKraev KrasimirKraeva MChakarov DUchikov A - Langerhans cell histiocytosis (LCH) is a myeloid neoplastic disorder characterized by lesions with CD1a-positive/Langerin (CD207)-positive histiocytes and inflammatory infiltrate that can cause local tissue damage and systemic inflammation. Clinical presentations range from single lesions with minimal impact to life-threatening disseminated disease. Therapy for systemic LCH has been established through serial trials empirically testing different chemotherapy agents and durations of therapy. However, fewer than 50% of patients who have disseminated disease are cured with the current standard-of-care vinblastine/prednisone/(mercaptopurine), and treatment failure is associated with long-term morbidity, including the risk of LCH-associated neurodegeneration. Historically, the nature of LCH-whether a reactive condition versus a neoplastic/malignant condition-was uncertain. Over the past 15 years, seminal discoveries have broadly defined LCH pathogenesis; specifically, activating mitogen-activated protein kinase pathway mutations (most frequently, BRAFV600E) in myeloid precursors drive lesion formation. LCH therefore is a clonal neoplastic disorder, although secondary inflammatory features contribute to the disease. These paradigm-changing insights offer a promise of rational cures for patients based on individual mutations, clonal reservoirs, and extent of disease. However, the pace of clinical trial development behind lags the kinetics of translational discovery. In this review, the authors discuss the current understanding of LCH biology, clinical characteristics, therapeutic strategies, and opportunities to improve outcomes for every patient through coordinated agent prioritization and clinical trial efforts. - Source: PubMed
Publication date: 2024/04/30
Bielamowicz KevinDimitrion PeterAbla OussamaBomken SimonCampbell PatrickCollin MatthewDegar BarbaraDiamond Eli LEckstein Olive SEl-Mallawany NaderFluchel MarkGoyal GauravHenry Michael MHermiston MichelleHogarty MichaelJeng MichaelJubran RimaLubega JosephKumar AshishLadisch StephanMcClain Kenneth LMerad MiriamMi Qing-ShengParsons D WilliamsPeckham-Gregory ErinPicarsic JenniferPrudowsky Zachary DRollins Barrett JShaw Peter HWistinghausen BirteRodriguez-Galindo CarlosAllen Carl E